ArticleSpine deformity2025
Growth modulation increases clinical success in vertebral body tethering.
Article in Spine deformity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Preoperative Fulcrum Flexibility >80% Is Associated With Clinical Success in Vertebral Body Tethering.Global spine journal · 2026Article
- Redefining Success and Characterizing Midterm Growth Modulation: Analysis of Radiographic Outcomes in 2 Years Following Vertebral Body Tethering.JB & JS open accessArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeThe relationship between skeletal maturity and postoperative growth modulation (GM) in patients treated with Vertebral Body Tethering (VBT) is poorly understood. We aimed to: (1) identify preoperative skeletal maturity factors associated with GM, and (2) assess the relationship between GM and postoperative success in patients treated with VBT.
methodsWe retrospectively reviewed radiographic data from 55 patients with a minimum follow-up of 2 years (2.6 ± 0.5). Changes in standing height and skeletal maturity (Sanders Stage [SS], Triradiate Cartilage [TRC], and Risser Stage [RS]) were assessed at all timepoints. Patients that exhibited GM were defined by ≥ 6° of deformity correction from first erect to any postoperative timepoint. Successful outcomes were defined by a Cobb Angle of ≤ 30° at latest follow-up.
resultsWe observed GM in 42% (23 of 55) of patients. GM was influenced by SS (p = 0.017) and TRC (p = 0.013), but not RS (p = 0.104). We observed a successful outcome in 91% of patients that exhibited GM compared to 44% of those that did not (p < 0.001; OR 12.9). No difference was identified in preoperative deformity magnitude or amount of initial correction achieved between patients that did and did not exhibit GM. Patients who exhibited GM had a higher revision rate (30.4%) than when compared to those who did not (3.0%, p = 0.005, OR 9.7).
conclusionPostoperative success after VBT is directly related to GM. Patients who modulate their deformity are 12.9 times more likely to exhibit a successful outcome and can be identified preoperatively based on SS or TRC.
Indexed as
Identifiers
40375048What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.